National Healthcare Properties, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $342.3M | $353.8M | $345.9M | $335.8M | $329.4M | $381.6M | $374.9M | $362.4M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $123.4M | $132.3M | $128.1M | $122.4M | $123.5M | $138.1M | $140.7M | $141.4M |
| Gross Margin | 36.0% | 37.4% | 37.0% | 36.4% | 37.5% | 36.2% | 37.5% | 39.0% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $24.2M | $22.4M | $18.9M | $17.3M | $16.8M | $21.6M | $20.5M | $17.3M |
| Operating Income | $3.3M | $-123.5M | $-4.7M | $-31.5M | $-37.4M | $-19.9M | $-31.8M | $-3.2M |
| Operating Margin | 1.0% | -34.9% | -1.4% | -9.4% | -11.4% | -5.2% | -8.5% | -0.9% |
| Interest Expense | — | $69.4M | $66.1M | $51.7M | $47.9M | $51.5M | $56.1M | $49.5M |
| Pretax Income | $-57.5M | $-190.0M | $-72.1M | $-79.4M | $-85.2M | $-71.4M | $-87.9M | $-52.8M |
| Income Tax Expense | $161.0K | $262.0K | $303.0K | $201.0K | $203.0K | $4.1M | $399.0K | $197.0K |
| Net Income | $-57.7M | $-190.3M | $-72.4M | $-79.6M | $-85.4M | $-75.5M | $-88.1M | $-52.8M |
| Net Margin | -16.9% | -53.8% | -20.9% | -23.7% | -25.9% | -19.8% | -23.5% | -14.6% |
| EPS (Basic) | $-2.51 | $-7.19 | $-3.04 | $-3.30 | $-0.82 | $-0.74 | $-0.88 | $-0.56 |
| EPS (Diluted) | $-2.51 | $-7.19 | $-3.04 | $-3.30 | $-0.82 | $-0.74 | $-0.88 | $-0.56 |
| Shares Outstanding (Basic) | 28.3M | 28.3M | 28.3M | 28.3M | 113.0M | 106.1M | 100.1M | 92.0M |
| Shares Outstanding (Diluted) | 28.3M | 28.3M | 28.3M | 28.3M | 113.0M | 106.1M | 100.1M | 92.0M |
| Dividends Per Share | — | $0.85 | $0.85 | $0.85 | — | $0.42 | $0.83 | $0.92 |